Ovation.io snares $5M in series A funding to support growth

money
The company’s flagship product, Ovation Diagnostic, is at the core of what it touts as a rapidly expanding laboratory commercialization platform. (Pixabay)

Ovation.io, a provider of cloud-based lab information systems, reeled in $5 million in series A funding that it plans to use to accelerate lab deployment and expand other features.

The round was led by Madrona Venture Group. Other participants included Borealis Ventures, Nat Turner and Zac Weinberg, as well as existing investors StagedotO and David Shaw.

Ovation.io provides operations and intelligence software for next-generation precision diagnostic labs and focuses on the challenges of critical functional areas of laboratory operations, business analytics and relationship support.

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

“We are excited to be partnering with our new and existing investors to continue supporting diagnostic labs as they play a crucially important role in patient diagnosis and treatment, and in accelerating development of new therapies” Barry Wark, Ovation.io co-founder and chief executive, said in a statement.

The company’s flagship product, Ovation Diagnostic, is at the core of what it touts as a rapidly expanding laboratory commercialization platform.

“Genomics and molecular testing labs have complex workflows that require new functionality that can only come from a modern SaaS and cloud-based solution,” S. Somasegar, Madrona’s managing director, said in a statement. “At the same time, these labs have clinical and genomic data that is being under-utilized to provide improved patient outcomes.”

Read more on

Suggested Articles

Phastar has signed up to use Medidata Solutions' trial cloud technology with an eye on boosting its work in the U.S.

Working with Sensyne Health, Evotec will support researchers at the university as they generate data to show the commercial viability of projects.

Parexel is looking to bolster its clinical trial work and compliance by signing a new deal with CluePoints.